致编辑的信：瑞司替罗治疗代谢功能障碍相关脂肪变性肝病：2024年10月更新AASLD实践指南

{"title":"致编辑的信：瑞司替罗治疗代谢功能障碍相关脂肪变性肝病：2024年10月更新AASLD实践指南","authors":"Jay H. Hoofnagleand, Averell H. Sherker","doi":"10.1097/hep.0000000000001264","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":177,"journal":{"name":"Hepatology","volume":"11 1","pages":""},"PeriodicalIF":18.0000,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Letter to the Editor: Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD practice guidance\",\"authors\":\"Jay H. Hoofnagleand, Averell H. Sherker\",\"doi\":\"10.1097/hep.0000000000001264\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":177,\"journal\":{\"name\":\"Hepatology\",\"volume\":\"11 1\",\"pages\":\"\"},\"PeriodicalIF\":18.0000,\"publicationDate\":\"2025-02-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/hep.0000000000001264\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/hep.0000000000001264","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}